PubMed:31213813 / 851-1019 JSON TXT

Annnotations TAB JSON ListView MergeView

Id	Subject	Object	Predicate	Lexical cue
T92	7-13	SO:0000146	denotes	capped
T95	14-25	3639	denotes	doxorubicin
T93	14-25	D004317	denotes	doxorubicin
T94	14-25	CHEBI:64816	denotes	doxorubicin
T96	14-25	CHEBI:28748	denotes	doxorubicin
T97	14-25	D004317	denotes	doxorubicin
T98	50-56	D012822	denotes	silica
T99	50-56	CHEBI:30563	denotes	silica
T100	50-56	D012822	denotes	silica
T101	57-70	CHEBI:50803	denotes	nanoparticles
T102	79-82	PR:O35763	denotes	MSN
T104	79-82	PR:000003008	denotes	MSN
T105	79-82	PR:P26041	denotes	MSN
T106	79-82	PR:P26038	denotes	MSN
T103	79-82	CVCL_9882	denotes	MSN
T107	148-151	CVCL_1K15	denotes	HER
T108	148-152	PR:P04626	denotes	HER2
T109	148-152	PR:000002082	denotes	HER2
T110	148-152	PR:Q03557	denotes	HER2
T111	148-152	PR:P34708	denotes	HER2
T112	148-152	PR:Q5AK64	denotes	HER2

Id	Subject	Object	Predicate	Lexical cue
T4	0-168	DRI_Background	denotes	(β-CD)-capped doxorubicin (DOX)-loaded mesoporous silica nanoparticles (termed MSN-BM/CD-HApt@DOX) for targeted delivery and selective targeting of HER2-positive cells.

Id	Subject	Object	Predicate	Lexical cue
T10	3-5	CVCL_5731\|Spontaneously_immortalized_cell_line\|Mus musculus	denotes	CD
T11	3-5	CVCL_W955\|Cancer_cell_line\|Homo sapiens	denotes	CD
T12	79-82	CVCL_9882\|Cancer_cell_line\|Homo sapiens	denotes	MSN
T13	83-85	CVCL_E481\|Transformed_cell_line\|Homo sapiens	denotes	BM
T14	83-85	CVCL_S926\|Spontaneously_immortalized_cell_line\|Lates calcarifer	denotes	BM
T15	86-88	CVCL_5731\|Spontaneously_immortalized_cell_line\|Mus musculus	denotes	CD
T16	86-88	CVCL_W955\|Cancer_cell_line\|Homo sapiens	denotes	CD